Quest Diagnostics Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 85.20
Dividend & Yield2.84$ (2.04%)
Beta 0.93
Market capitalization 15.67B
Operating cash flow 1.72B
ESG Scores 21.0

Company description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Sector: Healthcare - Industry: Diagnostics & Research

Financial Ratios
Quick Ratio1.44
Working Capital2.02
Return On Equity0.31
Debt To Equity0.62
Fixed Asset Ratio0.1
Fixed Interest Cover16.09

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Change To Liabilities 73M 452M 35M -149M
Total Cashflows From Investing Activities -411M -772M 21M -543M
Net Borrowings 832M -805M -2M -2M
Total Cash From Financing Activities 225M -1.27B -2.54B -1.73B
Change To Operating Activities -4M 3M -9M 53M
Issuance Of Stock 119M 189M 129M 123M
Net Income 858M 1.43B 2B 946M
Change In Cash 1.06B -34M -286M -557M
Effect Of Exchange Rate
Total Cash From Operating Activities 1.24B 2B 2.23B 1.72B
Depreciation 329M 361M 408M 437M
Change To Account Receivables -63M -455M 81M 246M
Other Cashflows From Financing Activities -71M -14M -137M -112M
Change To Netincome 21M 191M -257M 216M
Capital Expenditures -400M -418M -403M -404M

Income Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Research Development
Income Before Tax 1.13B 1.96B 2.68B 1.28B
Net Income 858M 1.43B 2B 946M
Selling General Administrative 1.46B 1.54B 1.7B 1.82B
Gross Profit 2.69B 3.64B 4.24B 3.47B
Ebit 1.15B 1.99B 2.45B 1.55B
Operating Income 1.15B 1.99B 2.45B 1.55B
Interest Expense -180M -166M -152M -148M
Income Tax Expense 247M 460M 597M 264M
Total Revenue 7.73B 9.44B 10.79B 9.88B
Cost Of Revenue 5.04B 5.79B 6.54B 6.42B
Total Other Income ExpenseNet -19M -29M 231M -273M
Net Income From Continuing Ops 886M 1.5B 2.08B 1.01B
Net Income Applicable To Common Shares 855M 1.43B 1.99B 942M

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Total Liabilities 7.08B 7.13B 7.05B 6.83B
Total Stockholder Equity 5.64B 6.76B 6.44B 5.89B
Other Current Liabilities 105M 119M 89M 99M
Total Assets 12.84B 14.03B 13.61B 12.84B
Common Stock 2M 2M 2M 2M
Other Current Assets 3M 2M 36M 26M
Retained Earnings 8.17B 9.3B 7.65B 8.29B
Treasury Stock -5.26B -5.39B -3.47B -4.69B
Cash 1.19B 1.16B 872M 315M
Total Current Liabilities 1.99B 1.78B 1.75B 1.55B
Other Stockholder Equity -39M -21M -14M -21M
Property, Plant, and Equipment 1.97B 2.23B 2.3B 2.35B
Total Current Assets 2.49B 3.06B 2.74B 1.9B
Net Tangible Assets -2.1B -1.28B -1.82B -2.42B
Net Receivables 1.06B 1.52B 1.44B 1.2B
Accounts Payable 263M 446M 357M 324M


Insider Transactions

Here are the insider transactions of stock shares related to Quest Diagnostics Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
DOHERTY CATHERINE TSale at price 141.42 per share.D2023-02-24Officer1.69k
PREVOZNIK MICHAEL ESale at price 141.42 per share.D2023-02-24General Counsel1.42k
DOHERTY CATHERINE TStock Award(Grant) at price 0.00 per share.D2023-02-23Officer3.84k
PREVOZNIK MICHAEL EStock Award(Grant) at price 0.00 per share.D2023-02-23General Counsel2.44k
RUSCKOWSKI STEPHEN HStock Award(Grant) at price 0.00 per share.D2023-02-23Director20.06k
DAVIS J E CAUSEYStock Award(Grant) at price 0.00 per share.D2023-02-23Chief Executive Officer17.44k
PLEWMAN PATRICKStock Award(Grant) at price 0.00 per share.D2023-02-23Officer1.92k
SAMAD SAMER ABDULStock Award(Grant) at price 0.00 per share.D2023-02-23Chief Financial Officer4.71k
DEPPE MICHAEL JStock Award(Grant) at price 0.00 per share.D2023-02-23Officer498
KUPPUSAMY KARTHIKStock Award(Grant) at price 0.00 per share.D2023-02-23Officer2.09k
DELANEY MARKStock Award(Grant) at price 0.00 per share.D2023-02-23Officer1.92k
GARDNER MARK AStock Award(Grant) at price 0.00 per share.D2023-02-23Officer1.92k
PLEWMAN PATRICKPurchase at price 146.75 per share.D2023-02-01Officer27
GREGG VICKY BPurchase at price 146.75 per share.D2023-02-01Director64
KUPPUSAMY KARTHIKPurchase at price 146.75 per share.D2023-02-01Officer13
RING TIMOTHY MSale at price 152.50 per share.D2022-12-01Director2.02k
RING TIMOTHY MConversion of Exercise of derivative security at price 53.12 - 62.01 per share.D2022-12-01Director2.02k
DOHERTY CATHERINE TSale at price 148.92 - 149.37 per share.D2022-11-28Officer40.77k
DOHERTY CATHERINE TConversion of Exercise of derivative security at price 86.63 per share.D2022-11-28Officer40.77k
RING TIMOTHY MSale at price 144.06 per share.D2022-11-01Director2k
RING TIMOTHY MConversion of Exercise of derivative security at price 60.78 - 62.01 per share.D2022-11-01Director2k
DAVIS J E CAUSEYStock Award(Grant) at price 0.00 per share.D2022-11-01Chief Executive Officer13.98k
DEPPE MICHAEL JSale at price 145.00 per share.D2022-10-26Officer15.5k
DEPPE MICHAEL JConversion of Exercise of derivative security at price 52.16 - 56.12 per share.D2022-10-26Officer15.5k
GREGG VICKY BPurchase at price 127.67 per share.D2022-10-19Director74
RING TIMOTHY MSale at price 123.39 per share.D2022-10-03Director2k
RING TIMOTHY MConversion of Exercise of derivative security at price 61.23 per share.D2022-10-03Director2k
RING TIMOTHY MSale at price 125.02 per share.D2022-09-01Director2k
RING TIMOTHY MConversion of Exercise of derivative security at price 61.23 per share.D2022-09-01Director2k
RING TIMOTHY MSale at price 136.04 per share.D2022-08-01Director2k
RING TIMOTHY MConversion of Exercise of derivative security at price 56.25 - 61.23 per share.D2022-08-01Director2k
GREGG VICKY BPurchase at price 134.47 per share.D2022-07-20Director70
RING TIMOTHY MSale at price 133.47 per share.D2022-07-01Director2k
RING TIMOTHY MConversion of Exercise of derivative security at price 56.25 - 58.69 per share.D2022-07-01Director2k
RUSCKOWSKI STEPHEN HSale at price 140.58 - 142.15 per share.D2022-05-25Chief Executive Officer24.89k
RUSCKOWSKI STEPHEN HConversion of Exercise of derivative security at price 86.63 - 103.57 per share.D2022-05-25Chief Executive Officer24.89k
RUSCKOWSKI STEPHEN HSale at price 140.12 - 142.25 per share.D2022-05-24Chief Executive Officer359.87k
RUSCKOWSKI STEPHEN HConversion of Exercise of derivative security at price 86.63 - 103.57 per share.D2022-05-24Chief Executive Officer359.87k
RING TIMOTHY MStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
WILENSKY GAIL RStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
MAIN TIMOTHY LStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
PFEIFFER GARY MStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
MORRISON DENISE MStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
GREGG VICKY BStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
DOI TRACEY CStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
LASSITER WRIGHT IIIStock Award(Grant) at price 0.00 per share.D2022-05-18Director1.29k
PREVOZNIK MICHAEL ESale at price 139.97 per share.D2022-05-17General Counsel50.6k
PREVOZNIK MICHAEL EConversion of Exercise of derivative security at price 66.51 per share.D2022-05-17General Counsel50.6k
GREGG VICKY BPurchase at price 134.88 per share.D2022-04-18Director61
DOHERTY CATHERINE TSale at price 135.21 per share.D2022-03-08Officer7.03k
PREVOZNIK MICHAEL ESale at price 135.21 per share.D2022-03-08General Counsel6.23k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Quest Diagnostics Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Quest Diagnostics Inc

Here is the result of two systematic investment strategies applied to Quest Diagnostics Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Quest Diagnostics Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Quest Diagnostics Inc:

Quest Diagnostics Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 35.07% on the backtest period.

Performance at glance

Performance

35.07 %

Latent gain

755.19 $

Invested capital

2153.52 $

Annualized return

8.47 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Quest Diagnostics Inc

This is the result of two momentum investment strategies applied to Quest Diagnostics Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Quest Diagnostics Inc

The following chart shows all the entries opened by the momentum investment system on Quest Diagnostics Inc:

Quest Diagnostics Inc momentum entries
  • The first momentum investment strategy would give 51.94% of return on Quest Diagnostics Inc. That represents 2407.33$ of latent gain with 4634.81$ of employed capital.
  • The second momentum investment strategy would give 48.02% of return on Quest Diagnostics Inc. That represents 1539.68$ of latent gain with 3206.11$ of employed capital.
Performance at glance (1Q Momentum)

Performance

51.94 %

Latent gain

2407.33 $

Invested capital

4634.81 $

Annualized return

15.82 %
Performance at glance (2Q Momentum)

Performance

48.02 %

Latent gain

1539.68 $

Invested capital

3206.11 $

Annualized return

13.12 %

Momentum equity curve on Quest Diagnostics Inc

The following chart shows the equity curve of the two momentum strategies applied to Quest Diagnostics Inc:

Quest Diagnostics Inc momentum equity

Note: the dividends potentially given by Quest Diagnostics Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Quest Diagnostics Inc

The following chart shows the employed capital evolution of the two momentum strategies on Quest Diagnostics Inc since the beginning:

Quest Diagnostics Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Quest Diagnostics Inc

Buy the dip entry openings on Quest Diagnostics Inc

Quest Diagnostics Inc

The performance achieved by the robo-advisor on Quest Diagnostics Inc is 33.86%. That represents 309.76$ of latent gain with 914.96$ of employed capital. The following chart shows Quest Diagnostics Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Quest Diagnostics Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

33.86 %

Latent gain

309.76 $

Invested capital

914.96 $

Annualized return

15.82 %

Equity curve of the strategy applied to Quest Diagnostics Inc

The following chart shows the result of the investment strategy applied to Quest Diagnostics Inc:

Quest Diagnostics Inc

Note: the dividends potentially given by Quest Diagnostics Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Quest Diagnostics Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Quest Diagnostics Inc:

Quest Diagnostics Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Quest Diagnostics Inc

In this section, I will compare the three previous investment strategies applied to Quest Diagnostics Inc.

Equity curve comparison on Quest Diagnostics Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Quest Diagnostics Inc investment strategy comparison

Employed capital comparison on Quest Diagnostics Inc

Quest Diagnostics Inc investment comparison

Performance comparison on Quest Diagnostics Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 35.07% 755.19$ 2153.52$ 8.47%
Momentum 1 quarter 51.94% 2407.33$ 4634.81$ 13.32%
Momentum 2 quarters 48.02% 1539.68$ 3206.11$ 13.12%
Non-directional 33.86% 309.76$ 914.96$ 15.82%
Annualized return comparison

Automatic investment

8.47 %

Momentum 1Q

13.12 %

Momentum 2Q

13.12 %

Non-directional

15.82 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Quest Diagnostics Inc:

Positive correlations

Most correlated stocks this year

  • Quest Diagnostics Inc

  • Most correlated stocks last 3 months

  • Quest Diagnostics Inc
  • GLORY SUN FIN
  • MALTERIES FCO-BEL.

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • SUN INTL
  • Lizhi Inc
  • HUABANG FIN

  • Note: The algorithm computes the probability of correlation between Quest Diagnostics Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Quest Diagnostics Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Quest Diagnostics Inc
    Country United States
    City Secaucus
    Address 500 Plaza Drive
    Phone 973 520 2700
    Website www.questdiagnostics.com
    FullTime employees 40000
    Industry Diagnostics & Research
    Sector Healthcare
    Exchange XNYS
    Ticker DGX
    Market www.nyse.com

    Quest Diagnostics Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0.1
    Peer Environment Performance 2.6416666666667
    Environment Percentile unknown
    Palm Oil no
    Nuclear no
    Fur Leather no
    GMO no
    Coal no
    Pesticides no
    Animal Testing no

    Social scores

    Social ESG Factors Scores
    Social Score 12.7
    Peer Social Performance 12.131111111111
    Social Percentile unknown
    Highest Controversy 3
    Peer Highest Controversy Performance 1.6486486486486
    Adult no
    Gambling no
    Alcoholic no
    Tobacco no
    Catholic no
    Controversial Weapons no
    Small Arms no
    Military Contract no
    Peer Count yes

    Related Controversy: Customer Incidents


    Governance scores

    Governance ESG Factors Scores
    Governance Score 8.2
    Peer Governance Performance 7.7769444444444
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: 21.0
    Environment Score: 0.1
    Social Score: 12.7
    Governance Score: 8.2

    ESG Performance: AVG_PERF

    Peer Group: Healthcare

    Peer Esg Score Performance: 22.573513513514

    Rating Year: 2023

    Rating Month: 1

    Max Age: 86400

    Percentile: 29